technology
PushButton AI Team ·
Sanofi just dropped $294M on AI. And you're still trying to figure out if that $200/month tool was worth it. Here's the thing nobody talks about: big companies get AI wrong constantly too. They just
Sanofi just dropped $294M on AI. And you're still trying to figure out if that $200/month tool was worth it.
Here's the thing nobody talks about: big companies get AI wrong constantly too. They just have deeper pockets to absorb the mistakes.
You bought a tool. Nobody used it. That's not a failure of intelligence — that's what happens when a solution gets purchased before the actual problem gets defined. It happens at every level of business, from startups to billion-dollar pharma giants.
What Sanofi is really doing isn't buying software. They're building around one specific bottleneck — drug discovery speed. They identified the pain point first, then found the tool to match.
That's the part the gurus skip.
Before you look at another AI platform, write down one repetitive task in your business that costs you real hours every week. One. Not a system overhaul. Just one friction point.
That single answer is worth more than any vendor demo you'll sit through this year.
Start there. Match the tool to that problem. Measure the time saved in 30 days.
What's the one task in your business you'd love to never do manually again?
#AIForBusiness #SmallBusiness #BusinessStrategy #AIImplementation
Sanofi's move marks the latest in a series of major investments by Big Pharma as the industry races to integrate AI into all aspects of their ...
